BioSpace News Archive

Companies working together to address serious public health concerns for at-risk patients

The Honourable Ginette Petitpas Taylor, Minister of Health, marked World No Tobacco Day by launching Canada’s Tobacco Strategy.

Kush Bottles, Inc. announced it has signed a lease for a new warehouse facility in Las Vegas to meet demand from the consumer market as well as support the current and new businesses entering the industry or expanding operations.

Olympus announced today the launch and 510(k) clearance of the ESG-300 Electrosurgery Generator.

DT MedTech, LLC (DTM) announced that the first Hintermann Series H2® Total Ankle Replacement Systems have successfully been implanted in patients in the United States.

Biocom announced the appointment of Taylor Crouch, Michael Farrington, Marc T. Morley and Peter Silvester to its board.

Keystone Heart Ltd., the leading medical device company focused on providing complete cerebral protection for patients undergoing cardiac procedures, today announced the launch of Phase II of the REFLECT trial to evaluate the safety and efficacy of the next generation of Keystone Heart -TriGUARD™ 3 Cerebral Embolic Protection device.

Pfizer’s Retacrit was finally cleared for marketing authorization. Retacrit is the first biosimilar ESA to become available in the US.

The Government of Canada is consulting Canadians on its latest proposal to protect bees and other pollinators from exposure to imidacloprid, a neonicotinoid pesticide.

Mauna Kea Technologies announced 20 abstracts supporting Cellvizio® to be presented at the Digestive Disease Week (DDW) Conference.